RiboActiv™ by Bioenergy Life Science
RiboActiv™ by Bioenergy Life Science
RiboActiv™ by Bioenergy Life Science is a precision, low-dose ingredient composed of Bioenergy Ribose, developed as an AMPK activator for energy and metabolic-focused formulations. Delivered at hormetic doses starting at 800 mg, it leverages the purine salvage pathway to support mitochondrial function and cellular energy metabolism. RiboActiv™ is patented, highly soluble, slightly sweet in taste, keto-friendly, Non-GMO, and authorized as a Novel Food by EFSA, making it suitable for functional foods, beverages, dietary supplements, and sports nutrition applications.
0 out of 5 stars (based on 0 endorsements)
General
Item #:
Company:
Technology:
Patented precision low-dose hormetic delivery of Bioenergy Ribose via purine salvage pathway
Name:
RiboActiv™
Ingredient/s:
Bioenergy Ribose
Categories:
Energy Booster, Metabolic Health, Muscle Performance
Dosage (min):
800 mg
Dosage (max):
MOQ:
Price kg:
Botanical Names:
Active/s:
Bioenergy Ribose
Assay:
Country of Origin:
Suppliers:
Bioenergy Life Science Inc.
Contact Information
Email:
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Ingredient Overview
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Featured Ingredients
Ingredient Highlights
RiboActiv™ features clinically supported actives shown to help:
- Supports cellular energy production via AMPK activation.*
- Enhances metabolic efficiency at precision low doses.*
- Promotes fat utilization without caloric restriction.*
- Improves mitochondrial function through purine salvage pathway.*
- Increases ATP availability during exercise and rest.*
- Supports endurance and performance in active formulations.*
Featured Content
Product type
Related Articles
Endorsement
0 out of 5 stars (based on 0 endorsements)
There are no reviews yet. Be the first one to write one.
